NCT06906731View on ClinicalTrials.gov

A Study of SHR-9803 for Injection in Patients With Advanced Solid Tumors

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Advanced Solid Tumors
Interventions
DRUG

SHR-9803

SHR-9803

Trial Locations (1)

150081

Harbin Medical University cancer hospital, Harbin

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT06906731 - A Study of SHR-9803 for Injection in Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter